Coping Strategies and Associated Symptom Burden Among Patients With Advanced Cancer
The Oncologist · 02.02.2024 · 29 (2) · 166-175
DOI: 10.1093/oncolo/oyad253 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Oncologist, online erschienen am 05.09.2023. Verfasst von Rony Dev und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Palliative Care, Rehabilitation, and Integrative Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA. Hauptthemen laut MEDLINE: Substance-Related Disorders, Neoplasms, Psychological Tests, Self Report. Die Arbeit wurde bisher 58-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NCI NIH HHS, NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Background
Few studies examine how patients with advanced cancer cope with stress. The objective of our study was to evaluate coping strategies adopted by patients with cancer and their relationship with symptom burden.
Methods
A secondary data analysis of a prospective cross-sectional survey of patients with cancer and tobacco use was conducted, which examined demographics, symptom burden (Edmonton Symptom Assessment System), and coping strategies (the Brief COPE Questionnaire). Demographic characteristics were summarized by standard summary statistics; we also examined associations between patient characteristics and coping strategies using t-test, rank-sum test, chi-squared test, or Fisher’s exact test depending on the distribution of data.
Results
Among 399 patients, the majority were female (60%), Caucasian (70%), the mean age was 56.5 (±12.0) years, and the most common malignancies were gastrointestinal (21%) and breast (19%). Patients with cancer adopted multiple adaptive coping strategies, most frequently acceptance (86.7%) and emotional support (79.9%), with humor (18.5%) being the least. Common maladaptive strategies included venting (14.5%) and self-distraction (36.6%), while substance use (1.0%) was infrequently reported. Of the adaptive strategies, female gender was significantly associated with higher engagement with emotional and instrumental support, positive reframing, religious coping, and acceptance (P < .05 for all). College educated patients reported significantly higher implementation of humor, planning, and acceptance. Maladaptive coping strategies such as denial were associated with increased pain and depression, while patients adopting emotional-focused strategies rated decreased emotional distress.
Conclusions
The majority of patients with advanced cancer reported adopting multiple, adaptive coping strategies, and a minority utilized maladaptive or avoidant strategies, rarely substance use, and may need additional psychological support.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Palliative Care, Rehabilitation, and Integrative Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
- Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Förderung
- NCI NIH HHS
- NIH HHS
- National Institutes of Health
Zitieren
APA
Dev, R., Agosta, M., Fellman, B., Reddy, A., Baldwin, S., Arthur, J., Haider, A., Carmack, C., Hui, D., & Bruera, E. (2024). Coping Strategies and Associated Symptom Burden Among Patients With Advanced Cancer. The Oncologist, 29(2), 166-175. https://doi.org/10.1093/oncolo/oyad253
Vancouver
Dev R, Agosta M, Fellman B, Reddy A, Baldwin S, Arthur J, et al. Coping Strategies and Associated Symptom Burden Among Patients With Advanced Cancer. The Oncologist. 2024;29(2):166-175. doi:10.1093/oncolo/oyad253
BibTeX
@article{Dev2024,
author = {Dev, Rony and Agosta, Monica and Fellman, Bryan and Reddy, Akhila and Baldwin, Sarah and Arthur, Joseph and Haider, Ali and Carmack, Cindy and Hui, David and Bruera, Eduardo},
title = {Coping Strategies and Associated Symptom Burden Among Patients With Advanced Cancer},
journal = {The Oncologist},
year = {2024},
volume = {29},
number = {2},
pages = {166--175},
doi = {10.1093/oncolo/oyad253}
}
EUVIMED